Skip to main content
logo
AbbVie Inc. (ABBV)
NYSE: ABBV · Real-Time Price · USD
294.96
+4.17 (1.43%)
Oct 30, 2026, 11:56 AM EDT - Market open

AbbVie Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Revenue
17,40416,99015,00216,61815,77615,42313,34315,10214,46014,46212,31014,30113,92713,86512,22515,12114,81214,58313,53814,886
Revenue Growth
10.32%10.16%12.43%10.04%9.10%6.64%8.39%5.60%3.83%4.31%0.69%-5.42%-5.97%-4.92%-9.70%1.58%3.28%4.47%4.06%7.42%
Gross Profit
13,11912,69910,78412,06611,31911,0779,34110,88510,25310,2608,24710,1209,5629,6578,25310,9879,81410,4399,51711,806
Operating Income
6,4836,8024,8245,6685,6005,7874,0604,9084,1394,9983,3774,4744,5734,9413,6726,1035,0305,7375,2176,790
Net Income
4,2183,6016871,8061769281,276-321,5511,3601,3598111,7672,0132282,4623,9319134,4754,023
Earnings Per Share
2.372.030.391.020.100.520.72-0.020.880.770.770.461.001.140.131.382.210.512.522.26
EPS Growth
2282.13%290.38%-46.06%--88.65%-32.40%-6.28%--12.32%-32.48%496.39%-66.95%-54.75%123.38%-94.89%-38.76%24.16%21.72%26.58%24889.89%

Revenue by Segment
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Immunology
9,1658,7867,2908,6267,8857,6316,2647,2947,0466,9715,3716,9536,7836,8135,5877,9257,6517,2076,1416,746
Neuroscience
3,3893,2282,8752,9612,8412,6832,2822,5092,3632,1621,9652,0942,0431,8851,6951,7101,6721,6581,4881,654
Oncology
1,6961,6501,6311,6641,6821,6761,6331,6911,6871,6341,5431,5091,5121,4781,4161,6311,6501,6501,6461,873
Aesthetics
1,1761,2821,1861,2861,1931,2791,1021,2981,2391,3901,2491,3711,2391,3841,3001,2871,3011,3711,3741,407
Other Key Products
9659359958841,0061,0378099128749629009689639479289869909719071,429
All Other
1,0131,1091,0256176606037477527268107448217827416919929251,0091,211594
Revenue (Total)
17,40416,99015,00216,61815,77615,42313,34315,10214,46014,46212,31014,30113,92713,86512,22515,12114,81214,58313,53814,886

Cash & Debt
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Cash & Investments
6,5696,5699,3915,2575,6716,4675,1765,5557,28513,15718,06912,81613,2908,7666,7229,22911,8819,9637,5729,830
Total Debt
70,88570,88572,91268,40068,84970,58570,02468,25071,32370,93874,35960,57961,18261,39362,46164,58369,99973,18873,64877,597
Net Cash (Debt)
-64,316-64,316-63,521-63,143-63,178-64,118-64,848-62,695-64,038-57,781-56,290-47,763-47,892-52,627-55,739-55,354-58,118-63,225-66,076-67,767
Net Cash Growth
--------------------
Net Cash Per Share
-36.30-36.32-35.79-35.59-35.65-36.20-36.60-35.44-36.14-32.63-31.75-26.95-27.04-29.72-31.38-31.13-32.72-35.60-37.16-38.11

Cash Flow & CapEx
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Operating Cash Flow
-3,4363,8295,2187,0245,1531,6357,0485,4472,2714,0404,7537,5746,3194,1937,4287,6025,0054,9085,075
Capital Expenditures
--322-265-329-381-269-235-291-249-241-193-205-219-178-175-213-177-143-162-187
Free Cash Flow
-3,1143,5644,8896,6434,8841,4006,7575,1982,0303,8474,5487,3556,1414,0187,2157,4254,8624,7464,888
Free Cash Flow Growth
--36.24%154.57%-27.64%27.80%140.59%-63.61%48.57%-29.33%-66.94%-4.26%-36.96%-0.94%26.31%-15.34%47.61%-3.80%3.56%1.22%6.84%

Margins
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Gross Margin
75.38%74.74%71.88%72.61%71.75%71.82%70.01%72.08%70.91%70.95%66.99%70.76%68.66%69.65%67.51%72.66%66.26%71.58%70.30%79.31%
Operating Margin
37.25%40.03%32.16%34.11%35.50%37.52%30.43%32.50%28.62%34.56%27.43%31.29%32.84%35.64%30.04%40.36%33.96%39.34%38.54%45.61%
Pretax Margin
27.75%25.18%6.93%16.05%4.53%10.08%12.45%-15.02%14.41%14.84%14.26%8.47%14.02%18.82%3.89%19.61%29.71%8.11%36.41%28.69%
Profit Margin
24.24%21.20%4.58%10.87%1.12%6.02%9.56%-0.21%10.73%9.40%11.04%5.67%12.69%14.52%1.86%16.28%26.54%6.26%33.05%27.02%
FCF Margin
-18.33%23.76%29.42%42.11%31.67%10.49%44.74%35.95%14.04%31.25%31.80%52.81%44.29%32.87%47.72%50.13%33.34%35.06%32.84%

Dividends
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Dividend Per Share
-1.7301.7301.7301.6401.6401.6401.6401.5501.5501.5501.5501.4801.4801.4801.4801.4101.4101.4101.410
Dividend Per Share Growth
-5.49%5.49%5.49%5.81%5.81%5.81%5.81%4.73%4.73%4.73%4.73%4.96%4.96%4.96%4.96%8.46%8.46%8.46%8.46%
Dividend Yield
-2.71%3.09%2.91%2.83%3.49%3.04%3.54%3.14%3.57%3.32%3.87%3.97%4.34%3.63%3.54%4.20%3.61%3.35%3.92%

Valuation
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
PE Ratio
44.8370.91106.9596.47174.2088.0789.20-68.6557.1854.1956.7840.6627.5337.3224.2517.7921.5323.0820.87
Forward PE
17.2616.8514.9616.5717.5316.5217.0614.8116.9314.7016.2613.9613.5912.1514.3012.729.9610.8811.4310.04
P/FCF Ratio
-24.4219.2522.6720.7817.9824.0917.6122.3317.0414.7312.4010.649.5911.9511.7810.8312.1812.9910.89
PS Ratio
7.006.916.126.606.865.626.465.576.285.515.935.044.774.244.964.924.104.725.054.26